Filters
Mechanisms of radioresistance of prostate cancer cells (GA13-17658S)
the molecular mechanisms of radioresistance of primary and metastatic CaP in relation expression. Our understanding of radioresistance of CaP is fundamental for future efforts......
EB - Genetika a molekulární biologie
- 2013 - 2016 •
- 9 124 tis. Kč •
- 9 124 tis. Kč •
- GA ČR
Řešení projektu: 1. 2. 2013 - 31. 12. 2016
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Grantová agentura České republiky
New therapeutic targets in overcoming radioresistance Systematic identification of genes driving response to radiation through the integration of functional genomics and transcriptomic profiling (NW24-03-00221)
of radioresistance, a characteristic feature of recurrent GBM, are not yet fully understood. Radioresistance is therefore a major topic of current concern in oncology research by the development of radioresistance in tumor...
Oncology
- 2024 - 2027 •
- 14 956 tis. Kč •
- 14 956 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2024 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Analysis and targeting of DNA damage signaling and repair mechanisms in glioblastomas and glioblastoma stem cells as a strategy to elucidate pathogenesis and search for individualized targeted treatments combined with standard therapy (NT11065)
) in glioblastoma, aiming at better understanding of molecular pathogenesis, radioresistance...
FD - Onkologie a hematologie
- 2010 - 2014 •
- 8 112 tis. Kč •
- 8 112 tis. Kč •
- MZ
Řešení projektu: 1. 9. 2010 - 31. 12. 2014
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
New biological methods of the received dose determination (2B08028)
In case of accidental irradiation of a human body (irradiation accidents, inappropriate manipulation with radioactive waste, terroristic attack) the medical personnel have to cope with the fundamental task to determine the received dose of ionizing r...
DN - Vliv životního prostředí na zdraví
- 2008 - 2010 •
- 6 339 tis. Kč •
- 4 490 tis. Kč •
- MŠMT
Řešení projektu: 1. 3. 2008 - 31. 12. 2010
Uznané náklady
Podpora ze státního rozpočtu (71%)
Poskytovatel: Ministerstvo školství, mládeže a tělovýchovy
Usage of tissue microRNAs for identification of patients who will benefit from the adjuvant radiotherapy after surgical resection of atypical meningioma (NV19-03-00559)
deregulated in meningioma and to be involved in processes associated with radioresistance...
Oncology
- 2019 - 2023 •
- 8 319 tis. Kč •
- 8 289 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2019 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Hidden Gems of Microbial Diversity Geothermally Heated Groundwaters as a Source of Phylogenetically Novel and Metabolically Rare Prokaryotes (GA25-15226S)
of the genetic basis of the radioresistance of isolated pure cultures, provide a deeper...
Microbiology
- 2025 - 2027 •
- 14 924 tis. Kč •
- 13 361 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2025 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (90%)
Poskytovatel: Grantová agentura České republiky
Characterizing & modifying complex response of head & neck tumor cells to different radiations - a step forward to combined personalized radiotherapy (GA16-12454S)
Head and neck tumors are aggressive neoplasms located close to vital tissues. However, only about 60% of tumors respond to noninvasive chemo-radiotherapy, the failure of which significantly worsens results of the subsequent rescue surgery as compared...
FD - Onkologie a hematologie
- 2016 - 2018 •
- 9 789 tis. Kč •
- 9 033 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2016 - 31. 12. 2018
Uznané náklady
Podpora ze státního rozpočtu (92%)
Poskytovatel: Grantová agentura České republiky
Molecular-genetic markers for prediction of radiotherapy response in head and neck cancer (NV16-29835A)
Currently, there is no clinical marker which allows a pre-therapeutic selection of patients with head and neck tumors that would profit more from the conservative therapy or primary surgery, respectively. We meaningfully contribute to solution of thi...
FD - Onkologie a hematologie
- 2016 - 2019 •
- 17 558 tis. Kč •
- 16 921 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2016 - 31. 12. 2019
Uznané náklady
Podpora ze státního rozpočtu (96%)
Poskytovatel: Ministerstvo zdravotnictví
FMISO-based protocol for adaptive radiotherapy in head and neck cancer (NU22-03-00435)
. These radioresistant regions can be detected with FMISO PET/CT. It has also been demonstrated...
Oncology
- 2022 - 2025 •
- 9 858 tis. Kč •
- 9 858 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2022 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 9 out of 9